{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:47:13Z","timestamp":1780055233100,"version":"3.54.0"},"reference-count":155,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The overweight\/obesity epidemic is a serious public health concern that affects &amp;gt;40% of adults globally and increases the risk of numerous chronic diseases, such as type 2 diabetes, heart disease, and various cancers. Multiple myeloma (MM) is a lymphohematopoietic cancer caused by the uncontrolled clonal expansion of plasma cells. Recent studies have shown that obesity is a risk factor not only for MM but also monoclonal gammopathy of undetermined significance (MGUS), a precursor disease state of MM. Furthermore, obesity may promote the transition from MGUS to MM. Thus, in this review, we summarize the epidemiological evidence regarding the role of obesity in MM and MGUS, discuss the biologic mechanisms that drive these disease processes, and detail the obesity-targeted pharmacologic and lifestyle interventions that may reduce the risk of progression from MGUS to MM.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010822","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T15:48:04Z","timestamp":1690386484000},"page":"5510-5523","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":23,"title":["It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4798-7565","authenticated-orcid":false,"given":"Ruth","family":"Choa","sequence":"first","affiliation":[{"name":"Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Panaroni","sequence":"additional","affiliation":[{"name":"Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noopur","family":"Raje","sequence":"additional","affiliation":[{"name":"Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"issue":"suppl 12","key":"2023092214150177800_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"issue":"9","key":"2023092214150177800_bib8","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1182\/blood.V95.9.2995.009k40c_2995_2997","article-title":"Benzene and multiple myeloma: appraisal of the scientific evidence","volume":"95","author":"Teitelbaum","year":"2000","journal-title":"Blood"},{"issue":"1","key":"2023092214150177800_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1745-6673-7-25","article-title":"Multiple myeloma and lifetime occupation: results from the EPILYMPH study","volume":"7","author":"Perrotta","year":"2012","journal-title":"J\u00a0Occup Med Toxicol"},{"issue":"10","key":"2023092214150177800_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1634\/theoncologist.2010-0206","article-title":"Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma","volume":"15","author":"Lichtman","year":"2010","journal-title":"Oncol"},{"issue":"9612","key":"2023092214150177800_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"2023092214150177800_bib11","doi-asserted-by":"crossref","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"BMJ"},{"issue":"11","key":"2023092214150177800_bib12","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1002\/j.1460-2075.1993.tb06099.x","article-title":"First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases\/collagenases","volume":"12","author":"Gomis-Ruth","year":"1993","journal-title":"EMBO J"},{"issue":"8","key":"2023092214150177800_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/bmt.2014.71","article-title":"The skinny on obesity and plasma cell myeloma: a review of the literature","volume":"49","author":"Carson","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2023092214150177800_bib14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer--viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2023092214150177800_bib15","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1182\/bloodadvances.2020001435","article-title":"Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance","volume":"4","author":"Clay-Gilmour","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"2023092214150177800_bib16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41375-019-0619-1","article-title":"Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance","volume":"34","author":"Chattopadhyay","year":"2020","journal-title":"Leukemia"},{"issue":"7","key":"2023092214150177800_bib17","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/s41375-019-0396-x","article-title":"Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma","volume":"33","author":"Thomsen","year":"2019","journal-title":"Leukemia"},{"issue":"5","key":"2023092214150177800_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"},{"issue":"13","key":"2023092214150177800_bib19","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"2023092214150177800_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"2023092214150177800_bib21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A\u00a0long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"2023092214150177800_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and White veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2023092214150177800_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40273-014-0243-x","article-title":"The epidemiology of obesity: a big picture","volume":"33","author":"Hruby","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"2023092214150177800_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"2023092214150177800_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","article-title":"Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women","volume":"116","author":"Landgren","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2023092214150177800_bib5","doi-asserted-by":"crossref","first-page":"djw264","DOI":"10.1093\/jnci\/djw264","article-title":"Obesity and the transformation of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based cohort study","volume":"109","author":"Chang","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"24","key":"2023092214150177800_bib6","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/bloodadvances.2017007609","article-title":"Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study","volume":"1","author":"Thordardottir","year":"2017","journal-title":"Blood Adv"},{"issue":"1","key":"2023092214150177800_bib23","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2352-3026(14)00037-4","article-title":"Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study","volume":"2","author":"Chang","year":"2015","journal-title":"Lancet Haematol"},{"issue":"5","key":"2023092214150177800_bib24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/10428194.2016.1236375","article-title":"Impact of metformin on the progression of MGUS to multiple myeloma","volume":"58","author":"Boursi","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2023092214150177800_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/leu.2014.295","article-title":"Diet-induced obesity promotes a myeloma-like condition in\u00a0vivo","volume":"29","author":"Lwin","year":"2015","journal-title":"Leukemia"},{"issue":"7","key":"2023092214150177800_bib154","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"issue":"12","key":"2023092214150177800_bib29","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s00277-019-03825-5","article-title":"Socioeconomic position is positively associated with monoclonal gammopathy of undetermined significance in a population-based cohort study","volume":"98","author":"Schmidt","year":"2019","journal-title":"Ann Hematol"},{"issue":"6","key":"2023092214150177800_bib155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajh.24355","article-title":"Reappraisal of risk factors for monoclonal gammopathy of undetermined significance","volume":"91","author":"Boursi","year":"2016","journal-title":"Am J Hematol"},{"issue":"5","key":"2023092214150177800_bib26","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ajcn\/87.5.1107","article-title":"Does social class predict diet quality?","volume":"87","author":"Darmon","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"2023092214150177800_bib27","doi-asserted-by":"crossref","first-page":"e0177151","DOI":"10.1371\/journal.pone.0177151","article-title":"Socio-economic status over the life course and obesity: systematic review and meta-analysis","volume":"12","author":"Newton","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2023092214150177800_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/epirev\/mxm007","article-title":"The obesity epidemic in the United States--gender, age, socioeconomic, racial\/ethnic, and geographic characteristics: a systematic review and meta-regression analysis","volume":"29","author":"Wang","year":"2007","journal-title":"Epidemiol Rev"},{"issue":"2","key":"2023092214150177800_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41375-021-01443-7","article-title":"A\u00a0comprehensive review of the impact of obesity on plasma cell disorders","volume":"36","author":"Parikh","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"2023092214150177800_bib33","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/ijc.22968","article-title":"Body mass index and risk of multiple myeloma: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"issue":"11","key":"2023092214150177800_bib34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","article-title":"Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies","volume":"47","author":"Wallin","year":"2011","journal-title":"Eur J Cancer"},{"issue":"4","key":"2023092214150177800_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41408-022-00659-9","article-title":"Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota","volume":"12","author":"Kleinstern","year":"2022","journal-title":"Blood Cancer J"},{"issue":"5","key":"2023092214150177800_bib36","first-page":"626","article-title":"Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case-control study","volume":"89","author":"Thompson","year":"2004","journal-title":"Haematologica."},{"issue":"9","key":"2023092214150177800_bib37","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00256-016-2425-4","article-title":"Abdominal adipose tissue in MGUS and multiple myeloma","volume":"45","author":"Veld","year":"2016","journal-title":"Skeletal Radiol"},{"issue":"5","key":"2023092214150177800_bib31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ijo.2015.243","article-title":"Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999-2004","volume":"40","author":"Batsis","year":"2016","journal-title":"Int J Obes"},{"issue":"6","key":"2023092214150177800_bib32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ijo.2013.216","article-title":"Changing distributions of body size and adiposity with age","volume":"38","author":"Vlassopoulos","year":"2014","journal-title":"Int J Obes"},{"issue":"1","key":"2023092214150177800_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cmet.2017.12.002","article-title":"Anatomical, physiological, and functional diversity of adipose tissue","volume":"27","author":"Zwick","year":"2018","journal-title":"Cell Metabol"},{"key":"2023092214150177800_bib39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fendo.2018.00788","article-title":"Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma","volume":"9","author":"Harmer","year":"2018","journal-title":"Front Endocrinol"},{"issue":"33","key":"2023092214150177800_bib40","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1038\/sj.onc.1204623","article-title":"The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications","volume":"20","author":"Hideshima","year":"2001","journal-title":"Oncogene"},{"issue":"11","key":"2023092214150177800_bib41","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/leu.2010.192","article-title":"Insulin is a potent myeloma cell growth factor through insulin\/IGF-1 hybrid receptor activation","volume":"24","author":"Sprynski","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"2023092214150177800_bib42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2141.1997.592708.x","article-title":"Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors","volume":"97","author":"Xu","year":"1997","journal-title":"Br J Haematol"},{"key":"2023092214150177800_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fonc.2018.00103","article-title":"The relation of obesity-related hormonal and cytokine levels with multiple myeloma and non-Hodgkin lymphoma","volume":"8","author":"Hosgood","year":"2018","journal-title":"Front Oncol"},{"issue":"4","key":"2023092214150177800_bib44","first-page":"1112","article-title":"Adiponectin inhibits the differentiation and maturation of osteoclasts via the mTOR pathway in multiple myeloma","volume":"45","author":"Liu","year":"2020","journal-title":"Int J Mol Med"},{"key":"2023092214150177800_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.05.033","article-title":"The adipose organ and multiple myeloma: impact of adipokines on tumor growth and potential sites for therapeutic intervention","volume":"53","author":"Allegra","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"22","key":"2023092214150177800_bib46","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1182\/blood-2011-01-330407","article-title":"Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease","volume":"118","author":"Fowler","year":"2011","journal-title":"Blood"},{"issue":"8","key":"2023092214150177800_bib47","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/oby.21894","article-title":"Circulating adiponectin levels differ between patients with multiple myeloma and its precursor disease","volume":"25","author":"Hofmann","year":"2017","journal-title":"Obesity"},{"issue":"10","key":"2023092214150177800_bib48","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2014.112","article-title":"PKA\/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells","volume":"28","author":"Medina","year":"2014","journal-title":"Leukemia"},{"issue":"5","key":"2023092214150177800_bib49","doi-asserted-by":"crossref","first-page":"R1220","DOI":"10.1152\/ajpregu.00397.2004","article-title":"Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes","volume":"288","author":"Ajuwon","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"52","key":"2023092214150177800_bib50","doi-asserted-by":"crossref","first-page":"86075","DOI":"10.18632\/oncotarget.13342","article-title":"Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"2023092214150177800_bib51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-0609.2009.01311.x","article-title":"Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma","volume":"83","author":"Reseland","year":"2009","journal-title":"Eur J Haematol"},{"issue":"12","key":"2023092214150177800_bib52","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1038\/leu.2017.146","article-title":"Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma","volume":"31","author":"Favreau","year":"2017","journal-title":"Leukemia"},{"issue":"8","key":"2023092214150177800_bib53","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bjc.2017.282","article-title":"Circulating resistin levels and risk of multiple myeloma in three prospective cohorts","volume":"117","author":"Santo","year":"2017","journal-title":"Br J Cancer"},{"issue":"7","key":"2023092214150177800_bib54","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3324\/haematol.2016.154062","article-title":"Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression","volume":"102","author":"Pang","year":"2017","journal-title":"Haematologica"},{"issue":"33","key":"2023092214150177800_bib55","doi-asserted-by":"crossref","first-page":"34329","DOI":"10.18632\/oncotarget.6020","article-title":"Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"2023092214150177800_bib56","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/endo.140.4.6637","article-title":"Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"issue":"3","key":"2023092214150177800_bib57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SAP.0b013e31802f6513","article-title":"Leptin increases extracellular matrix mineralization of human osteoblasts from heterotopic ossification and normal bone","volume":"59","author":"Handschin","year":"2007","journal-title":"Ann Plast Surg"},{"issue":"4","key":"2023092214150177800_bib58","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jcb.10156","article-title":"Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling","volume":"85","author":"Gordeladze","year":"2002","journal-title":"J\u00a0Cell Biochem"},{"issue":"2","key":"2023092214150177800_bib59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.2002.17.2.200","article-title":"Leptin inhibits osteoclast generation","volume":"17","author":"Holloway","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"2023092214150177800_bib60","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bone.2003.11.020","article-title":"Leptin deficiency produces contrasting phenotypes in bones of the limb and spine","volume":"34","author":"Hamrick","year":"2004","journal-title":"Bone"},{"issue":"8","key":"2023092214150177800_bib61","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/jbmr.406","article-title":"Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob\/ob mice","volume":"26","author":"Bartell","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"issue":"9","key":"2023092214150177800_bib62","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/stem.144","article-title":"Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells","volume":"27","author":"Lee","year":"2009","journal-title":"Stem Cell"},{"issue":"14","key":"2023092214150177800_bib63","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M110.152405","article-title":"Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1","volume":"286","author":"Tu","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"2023092214150177800_bib64","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fendo.2019.00815","article-title":"Adiponectin deficiency triggers bone loss by up-regulation of osteoclastogenesis and down-regulation of osteoblastogenesis","volume":"10","author":"Yang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023092214150177800_bib65","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.3389\/fimmu.2019.02925","article-title":"TNF-\u03b1 directly enhances osteocyte RANKL expression and promotes osteoclast formation","volume":"10","author":"Marahleh","year":"2019","journal-title":"Front Immunol"},{"issue":"9","key":"2023092214150177800_bib66","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/jcb.25151","article-title":"Double stranded RNA-dependent protein kinase is necessary for TNF-\u03b1-induced osteoclast formation in\u00a0vitro and in\u00a0vivo","volume":"116","author":"Shinohara","year":"2015","journal-title":"J\u00a0Cell Biochem"},{"issue":"3","key":"2023092214150177800_bib67","doi-asserted-by":"crossref","first-page":"150258","DOI":"10.1098\/rsob.150258","article-title":"TNF-\u03b1-induced NF-\u03baB activation upregulates microRNA-150-3p and inhibits osteogenesis of mesenchymal stem cells by targeting \u03b2-catenin","volume":"6","author":"Wang","year":"2016","journal-title":"Open Biol"},{"issue":"1","key":"2023092214150177800_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12020-015-0554-5","article-title":"Preservation of high-fat diet-induced femoral trabecular bone loss through genetic target of TNF-\u03b1","volume":"50","author":"Zhang","year":"2015","journal-title":"Endocrine"},{"issue":"7","key":"2023092214150177800_bib69","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1038\/emm.2017.100","article-title":"Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21","volume":"49","author":"Lee","year":"2017","journal-title":"Exp Mol Med"},{"issue":"3","key":"2023092214150177800_bib70","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/jlb.1A1215-543R","article-title":"IL-1\u03b2 differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets","volume":"100","author":"Cao","year":"2016","journal-title":"J\u00a0Leukoc Biol"},{"issue":"11","key":"2023092214150177800_bib71","doi-asserted-by":"crossref","first-page":"jcs213967","DOI":"10.1242\/jcs.213967","article-title":"IL1\u03b2 and TNF\u03b1 promote RANKL-dependent adseverin expression and osteoclastogenesis","volume":"131","author":"Wang","year":"2018","journal-title":"J\u00a0Cell Sci"},{"issue":"1","key":"2023092214150177800_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2119\/molmed.2012.00058","article-title":"IL-1\u03b2 inhibits human osteoblast migration","volume":"19","author":"Hengartner","year":"2013","journal-title":"Mol Med"},{"issue":"2","key":"2023092214150177800_bib73","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/14756366.2011.587415","article-title":"Luteolin downregulates IL-1\u03b2-induced MMP-9 and -13 expressions in osteoblasts via inhibition of ERK signalling pathway","volume":"27","author":"Yang","year":"2012","journal-title":"J\u00a0Enzym Inhib Med Chem"},{"issue":"3","key":"2023092214150177800_bib74","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00774-014-0598-2","article-title":"Interleukin-1-induced acute bone resorption facilitates the secretion of fibroblast growth factor 23 into the circulation","volume":"33","author":"Yamazaki","year":"2015","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"8","key":"2023092214150177800_bib75","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00198-019-04996-7","article-title":"High FGF23 levels are associated with impaired trabecular bone microarchitecture in patients with osteoporosis","volume":"30","author":"Rupp","year":"2019","journal-title":"Osteoporos Int"},{"key":"2023092214150177800_bib76","first-page":"3431828","article-title":"Circulating miR-34a and bone mineral density of Brazilian very-old adults","volume":"2020","author":"N\u00f3brega","year":"2020","journal-title":"J\u00a0Aging Res"},{"issue":"10","key":"2023092214150177800_bib77","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1507\/endocrj.EJ21-0005","article-title":"Extracellular vesicles derived from T-cell acute lymphoblastic leukemia inhibit osteogenic differentiation of bone marrow mesenchymal stem cells via miR-34a-5p","volume":"68","author":"Yuan","year":"2021","journal-title":"Endocr J"},{"key":"2023092214150177800_bib78","doi-asserted-by":"crossref","first-page":"1893520","DOI":"10.1155\/2017\/1893520","article-title":"miR-155 inhibits mouse osteoblast differentiation by suppressing SMAD5 expression","volume":"2017","author":"Gu","year":"2017","journal-title":"BioMed Res Int"},{"issue":"5","key":"2023092214150177800_bib79","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00774-019-00997-y","article-title":"miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN\/PI3K\/AKT\/FoxO1 pathway","volume":"37","author":"Lou","year":"2019","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"1","key":"2023092214150177800_bib80","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41598-017-00466-4","article-title":"MiR-503 promotes bone formation in distraction osteogenesis through suppressing Smurf1 expression","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep"},{"issue":"7-8","key":"2023092214150177800_bib81","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.lfs.2011.06.007","article-title":"Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells","volume":"89","author":"Kanda","year":"2011","journal-title":"Life Sci"},{"key":"2023092214150177800_bib82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biochi.2014.01.002","article-title":"FFAs-ROS-ERK\/P38 pathway plays a key role in adipocyte lipotoxicity on osteoblasts in co-culture","volume":"101","author":"Dong","year":"2014","journal-title":"Biochimie"},{"key":"2023092214150177800_bib83","doi-asserted-by":"crossref","first-page":"38014","DOI":"10.1038\/srep38014","article-title":"NADPH oxidase gp91","volume":"6","author":"Kang","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"2023092214150177800_bib84","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671.014k24_671_675","article-title":"Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma","volume":"96","author":"Choi","year":"2000","journal-title":"Blood"},{"issue":"5","key":"2023092214150177800_bib85","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/0008-5472.CAN-04-1687","article-title":"Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients","volume":"65","author":"Zannettino","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"2023092214150177800_bib86","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood-2005-03-1080","article-title":"IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma","volume":"106","author":"Ehrlich","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2023092214150177800_bib87","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2003-11-3839","article-title":"Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion","volume":"104","author":"Abe","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2023092214150177800_bib88","doi-asserted-by":"crossref","first-page":"e35981","DOI":"10.1371\/journal.pone.0035981","article-title":"Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent","volume":"7","author":"Feyler","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"2023092214150177800_bib89","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"2023092214150177800_bib90","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1038\/s41467-020-16878-2","article-title":"Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis","volume":"11","author":"Suchacki","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"2023092214150177800_bib91","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/en.2015-1477","article-title":"Expansion of bone marrow adipose tissue during caloric restriction is associated with increased circulating glucocorticoids and not with hypoleptinemia","volume":"157","author":"Cawthorn","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"2023092214150177800_bib92","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","article-title":"Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human","volume":"150","author":"Wu","year":"2012","journal-title":"Cell"},{"issue":"7","key":"2023092214150177800_bib93","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.leu.2404658","article-title":"Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells","volume":"21","author":"Caers","year":"2007","journal-title":"Leukemia"},{"key":"2023092214150177800_bib94","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2016.00102","article-title":"Changes in skeletal integrity and marrow adiposity during high-fat diet and after weight loss","volume":"7","author":"Scheller","year":"2016","journal-title":"Front Endocrinol"},{"issue":"5","key":"2023092214150177800_bib95","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"2023092214150177800_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-019-0778-6","article-title":"Cancer-associated adipocytes: key players in breast cancer progression","volume":"12","author":"Wu","year":"2019","journal-title":"J\u00a0Hematol Oncol"},{"issue":"3","key":"2023092214150177800_bib97","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","article-title":"The obese adipose tissue microenvironment in cancer development and progression","volume":"15","author":"Quail","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2023092214150177800_bib98","doi-asserted-by":"crossref","first-page":"eaau9087","DOI":"10.1126\/scitranslmed.aau9087","article-title":"Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease","volume":"11","author":"Liu","year":"2019","journal-title":"Sci Transl Med"},{"key":"2023092214150177800_bib99","doi-asserted-by":"crossref","first-page":"eaay8203","DOI":"10.1126\/scisignal.aay8203","article-title":"Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells","volume":"13","author":"Liu","year":"2020","journal-title":"Sci Signal"},{"issue":"11","key":"2023092214150177800_bib100","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.ajpath.2016.07.012","article-title":"Adipocyte-lineage cells support growth and dissemination of multiple myeloma in bone","volume":"186","author":"Trotter","year":"2016","journal-title":"Am J Pathol"},{"issue":"1","key":"2023092214150177800_bib101","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2016.06.010","article-title":"Adipocytes contribute to the growth and progression of multiple myeloma: unraveling obesity related differences in adipocyte signaling","volume":"380","author":"Bullwinkle","year":"2016","journal-title":"Cancer Lett"},{"issue":"3","key":"2023092214150177800_bib102","doi-asserted-by":"crossref","first-page":"e10173","DOI":"10.1002\/jbm4.10173","article-title":"Multiple myeloma and fatty acid metabolism","volume":"3","author":"Masarwi","year":"2019","journal-title":"JBMR Plus"},{"issue":"3","key":"2023092214150177800_bib103","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/21623945.2017.1367881","article-title":"Bone marrow adipocytes","volume":"6","author":"Horowitz","year":"2017","journal-title":"Adipocyte"},{"key":"2023092214150177800_bib104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bone.2018.01.023","article-title":"Development of a 3D bone marrow adipose tissue model","volume":"118","author":"Fairfield","year":"2019","journal-title":"Bone"},{"issue":"3","key":"2023092214150177800_bib105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevOncog.2013006145","article-title":"Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism","volume":"18","author":"Mistry","year":"2013","journal-title":"Crit Rev Oncog"},{"issue":"6","key":"2023092214150177800_bib106","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"2023092214150177800_bib107","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1038\/s41598-020-67105-3","article-title":"Metabolomic and lipidomic profiling of bone marrow plasma differentiates patients with monoclonal gammopathy of undetermined significance from multiple myeloma","volume":"10","author":"Gonsalves","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"2023092214150177800_bib108","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metabol"},{"issue":"1","key":"2023092214150177800_bib109","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","article-title":"Emerging roles of lipid metabolism in cancer metastasis","volume":"16","author":"Luo","year":"2017","journal-title":"Mol Cancer"},{"issue":"3","key":"2023092214150177800_bib110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni.3664","article-title":"Gsk3 is a metabolic checkpoint regulator in B cells","volume":"18","author":"Jellusova","year":"2017","journal-title":"Nat Immunol"},{"key":"2023092214150177800_bib111","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.isci.2018.07.005","article-title":"Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling","volume":"5","author":"Waters","year":"2018","journal-title":"iScience"},{"issue":"10","key":"2023092214150177800_bib112","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1074\/jbc.M114.551051","article-title":"Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for ATP-citrate lyase in lipopolysaccharide-induced differentiation","volume":"289","author":"Dufort","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"2023092214150177800_bib113","doi-asserted-by":"crossref","first-page":"274585","DOI":"10.1155\/2015\/274585","article-title":"Obesity and cancer progression: is there a role of fatty acid metabolism?","volume":"2015","author":"Balaban","year":"2015","journal-title":"BioMed Res Int"},{"issue":"50","key":"2023092214150177800_bib114","doi-asserted-by":"crossref","first-page":"82783","DOI":"10.18632\/oncotarget.12635","article-title":"The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance","volume":"7","author":"Al Fayi","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"2023092214150177800_bib115","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cmet.2018.07.006","article-title":"Circulating adipose fatty acid binding protein is a new link underlying obesity-associated breast\/mammary tumor development","volume":"28","author":"Hao","year":"2018","journal-title":"Cell Metabol"},{"key":"2023092214150177800_bib116","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1471-2407-11-302","article-title":"Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma","volume":"11","author":"T\u00f6lle","year":"2011","journal-title":"BMC Cancer"},{"issue":"3","key":"2023092214150177800_bib117","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","article-title":"Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome","volume":"52","author":"Xu","year":"2006","journal-title":"Clin Chem"},{"issue":"11","key":"2023092214150177800_bib118","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"issue":"11","key":"2023092214150177800_bib119","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.18632\/oncotarget.1482","article-title":"Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms","volume":"4","author":"Herroon","year":"2013","journal-title":"Oncotarget"},{"issue":"pt B","key":"2023092214150177800_bib120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mce.2017.02.002","article-title":"The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5","volume":"462","author":"Guaita-Esteruelas","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"41","key":"2023092214150177800_bib121","doi-asserted-by":"crossref","first-page":"69408","DOI":"10.18632\/oncotarget.11242","article-title":"Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myeloma","volume":"8","author":"Schneiderova","year":"2017","journal-title":"Oncotarget"},{"issue":"18","key":"2023092214150177800_bib122","first-page":"4693","article-title":"Melatonin inhibition of cancer growth in\u00a0vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events","volume":"59","author":"Blask","year":"1999","journal-title":"Cancer Res"},{"issue":"8","key":"2023092214150177800_bib123","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1158\/2159-8290.CD-17-1371","article-title":"Adipocyte-derived lipids mediate melanoma progression via FATP proteins","volume":"8","author":"Zhang","year":"2018","journal-title":"Cancer Discov"},{"issue":"6","key":"2023092214150177800_bib124","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.2021013832","article-title":"Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins","volume":"139","author":"Panaroni","year":"2022","journal-title":"Blood."},{"issue":"11","key":"2023092214150177800_bib125","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/s41375-019-0470-4","article-title":"Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells","volume":"33","author":"Mishra","year":"2019","journal-title":"Leukemia"},{"issue":"4","key":"2023092214150177800_bib126","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1582-4934.2010.01083.x","article-title":"The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth","volume":"15","author":"Feng","year":"2011","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"2023092214150177800_bib127","first-page":"27","article-title":"Effectiveness of metformin on weight loss in non-diabetic individuals with obesity","volume":"121","author":"Seifarth","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"2023092214150177800_bib128","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.4161\/cc.20770","article-title":"Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells","volume":"11","author":"Pan","year":"2012","journal-title":"Cell Cycle"},{"issue":"6","key":"2023092214150177800_bib129","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023092214150177800_bib130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ebiom.2017.10.009","article-title":"Attenuation of CD4","volume":"25","author":"Kunisada","year":"2017","journal-title":"EBioMedicine"},{"issue":"10","key":"2023092214150177800_bib131","doi-asserted-by":"crossref","first-page":"e1633235","DOI":"10.1080\/2162402X.2019.1633235","article-title":"Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy","volume":"8","author":"Verdura","year":"2019","journal-title":"OncoImmunology"},{"issue":"3","key":"2023092214150177800_bib132","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/bjc.2014.307","article-title":"The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma","volume":"111","author":"Wu","year":"2014","journal-title":"Br J Cancer"},{"key":"2023092214150177800_bib133","first-page":"964","article-title":"A\u00a0randomized placebo-controlled phase 2 study of metformin for the prevention of progression of monoclonal gammopathy of undetermined significance and low risk smoldering multiple myeloma","author":"Marinac","year":"2023","journal-title":"Leukemia"},{"issue":"5","key":"2023092214150177800_bib134","first-page":"335","article-title":"Simvastatin induces death of multiple myeloma cell lines","volume":"52","author":"Gronich","year":"2004","journal-title":"J\u00a0Invest Med"},{"issue":"3","key":"2023092214150177800_bib135","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41375-020-0962-2","article-title":"The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma","volume":"35","author":"Longo","year":"2021","journal-title":"Leukemia"},{"key":"2023092214150177800_bib136","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biopha.2015.12.017","article-title":"Statins inhibited the MIP-1\u03b1 expression via inhibition of Ras\/ERK and Ras\/Akt pathways in myeloma cells","volume":"78","author":"Tsubaki","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"33","key":"2023092214150177800_bib137","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1200\/JCO.2016.68.3482","article-title":"Statins are associated with reduced mortality in multiple myeloma","volume":"34","author":"Sanfilippo","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"2023092214150177800_bib138","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1016\/j.clml.2020.02.011","article-title":"Receipt of statins is associated with lower risk of multiple myeloma: systematic review and meta-analysis","volume":"20","author":"Ponvilawan","year":"2020","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"issue":"5","key":"2023092214150177800_bib139","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41375-023-01874-4","article-title":"Dietary and microbiome evidence in multiple myeloma and other plasma cell disorders","volume":"37","author":"Shah","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"2023092214150177800_bib140","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1038\/s41467-018-07305-8","article-title":"Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression","volume":"9","author":"Calcinotto","year":"2018","journal-title":"Nat Commun"},{"issue":"9","key":"2023092214150177800_bib141","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jnutbio.2010.07.009","article-title":"Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils","volume":"22","author":"Vinolo","year":"2011","journal-title":"J\u00a0Nutr Biochem"},{"issue":"1","key":"2023092214150177800_bib142","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8","volume":"12","author":"Luu","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"2023092214150177800_bib143","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40168-020-00854-5","article-title":"Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria","volume":"8","author":"Jian","year":"2020","journal-title":"Microbiome"},{"issue":"5","key":"2023092214150177800_bib144","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-01-690743","article-title":"Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target","volume":"128","author":"Bolzoni","year":"2016","journal-title":"Blood"},{"issue":"23","key":"2023092214150177800_bib145","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1158\/1078-0432.CCR-22-0723","article-title":"Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets","volume":"28","author":"Shah","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2023092214150177800_bib146","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s10552-015-0625-1","article-title":"Fish consumption and risk of myeloma: a meta-analysis of epidemiological studies","volume":"26","author":"Wang","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"11","key":"2023092214150177800_bib147","doi-asserted-by":"crossref","first-page":"e0206047","DOI":"10.1371\/journal.pone.0206047","article-title":"Dietary intake is associated with risk of multiple myeloma and its precursor disease","volume":"13","author":"Thordardottir","year":"2018","journal-title":"PLoS One"},{"issue":"suppl 16","key":"2023092214150177800_bib148","doi-asserted-by":"crossref","first-page":"e20062","DOI":"10.1200\/JCO.2023.41.16_suppl.e20062","article-title":"Risk of MGUS, a multiple myeloma precursor, in relation to food and beverage intake in the National Health and Nutrition Examination Survey (NHANES)","volume":"41","author":"Joseph","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 16","key":"2023092214150177800_bib149","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1200\/JCO.2023.41.16_suppl.10635","article-title":"Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP cohort","volume":"41","author":"Parikh","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"2023092214150177800_bib150","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/ijc.32928","article-title":"Prediagnosis dietary pattern and survival in patients with multiple myeloma","volume":"147","author":"Lee","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"2023092214150177800_bib151","doi-asserted-by":"crossref","first-page":"pkz025","DOI":"10.1093\/jncics\/pkz025","article-title":"Dietary pattern and risk of multiple myeloma in two large prospective US Cohort Studies","volume":"3","author":"Lee","year":"2019","journal-title":"JNCI Cancer Spectr"},{"issue":"suppl 1","key":"2023092214150177800_bib152","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1182\/blood-2022-159794","article-title":"A\u00a0randomized placebo controlled study of a plant-based dietary versus supplement versus placebo intervention in patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) - the nutrition prevention (NUTRIVENTION-3) study","volume":"140","author":"Shah","year":"2022","journal-title":"Blood"},{"issue":"suppl 1","key":"2023092214150177800_bib153","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1182\/blood-2022-163281","article-title":"A\u00a0Pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of progression","volume":"140","author":"Shah","year":"2022","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5510\/2079915\/blooda_adv-2023-010822-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5510\/2079915\/blooda_adv-2023-010822-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T14:16:26Z","timestamp":1695392186000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/18\/5510\/497093\/It-is-worth-the-weight-obesity-and-the-transition"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":155,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,9,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010822","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]}}}